摘要
Purpose: To evaluate the impact of neutrophil-to-lymphocyte ratio (NLR) and preoperative prognostic nutritional index (PNI) on prognosis of gastric cancer (GC) after adjuvant FOLFOX chemotherapy.Materials and Methods: Data on 749 GC patients who received operation after by adjuvant FOLFOX chemotherapy between January 2013 and December 2015 were enrolled in this study, retrospectively. Receiver-operating characteristic curve analysis was employed to assess optimal cutoff thresholds for PNI and NLR. The GC subjects having a low PNI (<52.8) and high NLR (>1.79) received a score of 2. Any variable that met these standards was scored as 1. If none of the two variables met these standards of the patient was assigned a score of 0. Correlation between PNI-NLR score and GC stage was also evaluated.Results: The mean overall survival (OS) and 5-year OS rate for subjects with PNI-NLR = 2 was lower than those of subjects with PNI-NLR = 1, or 0 (40.9% vs. 52.1%, 76.4% [46.0 vs. 61.0], 68.0 months, p <= 0.001). In multivariate analyses, the PNI-NLR score (p <= 0.001) and WHO grade (p <= 0.001) showed potential to independently influence OS.Conclusions: High PNI-NLR scores can independently affect worse prognosis of GC. Thus, it can be utilized to differentiate low risk from high risk subjects.
学科与关键词
- Prognostic importance of the preoperative New-Naples prognostic score for patients with gastric cancerWang, Hao; Fang, Tianyi; Yin, Xin; Lou, Shenghan; Han, Bangling; Gao, Jialiang; Wang, Yufei; Wang, Xibo; Zhang, Daoxu; Wang, Yimin; Zhang, Yao; Xue, Yingwei*Cancer Medicine, 2023, 12(2): 1358-1375.被引 3
- Preoperative Prognostic Nutrition Index as a Prognostic Indicator of Survival in Elderly Patients Undergoing Gastric Cancer SurgeryZhang, Xiaonan; Fang, Huimin; Zeng, Zhigang; Zhang, Kaijun; Lin, Zhanyi; Deng, Gang; Deng, Weiping; Guan, Lichang; Wei, Xuebiao; Li, Xinyi; Jiang, Lei*; Xu, LishuCancer Management and Research, 2021, 13: 5263-5273.被引 13
- Nutritional Risk Index as a Prognostic Factor Predicts the Clinical Outcomes in Patients With Stage III Gastric CancerSong, Haibin; Sun, Hongkai; Yang, Laishou; Gao, Hongyu; Cui, Yongkang; Yu, Chengping; Xu, Haozhi; Li, Linqiang*Frontiers in Oncology, 2022, 12: 880419.被引 3
